Core Points - The company plans to use part of its idle raised funds to temporarily supplement working capital, with an amount not exceeding 12 million RMB and a duration of no more than 12 months from the board's approval date [1][4]. Summary of Fundraising Situation - The company was approved to issue up to 45.38 million new shares, with an actual issuance of 41,046,070 shares at a price of 12.52 RMB per share, raising a total of approximately 513.90 million RMB, netting about 502.38 million RMB after deducting issuance costs [1][2]. - As of June 16, 2025, the actual amount used for fundraising projects was approximately 496.14 million RMB, leaving a remaining amount of approximately 26.41 million RMB [2]. Summary of Fundraising Investment Projects - The company has several projects with varying levels of investment and usage, including: - National Class I anti-cancer drug project with a committed investment of 156.10 million RMB, with 34.94 million RMB used [2]. - Raw material drug project with a committed investment of 46 million RMB, fully utilized [2]. - Automation warehouse project with a committed investment of 36.80 million RMB, with 8.12 million RMB used [2]. - The total amount for temporary working capital supplementation is set at 12 million RMB [3][4]. Approval Process for Fund Usage - The board and supervisory committee approved the plan to use idle funds on June 25, 2025, ensuring compliance with relevant regulations and that it would not affect the normal progress of fundraising investment projects [4][5]. - The supervisory committee and the sponsor institution both expressed support for the plan, confirming it aligns with regulatory requirements and does not harm shareholder interests [5].

Core Points - The company has approved the temporary use of idle raised funds for working capital on multiple occasions, totaling RMB 16,166 million [1][2][3] - The funds will be returned to the designated account ahead of schedule, with notifications sent to the sponsor and representative [3] Summary by Document Document 1 - On August 29, 2024, the company approved the use of up to RMB 23.66 million of idle raised funds for temporary working capital, with a usage period not exceeding 12 months [1] Document 2 - On September 5, 2024, the company approved the use of up to RMB 130 million of idle raised funds for temporary working capital, with a usage period not exceeding 12 months [2] Document 3 - On September 26, 2024, the company approved the use of up to RMB 8 million of idle raised funds for temporary working capital, with a usage period not exceeding 12 months [3] - As of June 20, 2025, the company has fully repaid the total of RMB 16.166 million used for temporary working capital to the designated account [3]

Summary of Key Points Core Viewpoint - The company, Greebo (Jiangsu) Co., Ltd., is utilizing part of its idle raised funds to temporarily supplement its working capital, ensuring that this does not affect the progress of its investment projects [1][6]. Fundraising Basic Situation - The company raised a total of RMB 374,950.90 million from its initial public offering, with a net amount of RMB 354,439.66 million after deducting issuance costs [1][2]. - The funds were deposited into a special account on January 31, 2023, and were verified by Ernst & Young Huaming on February 1, 2023 [2]. Investment Project Situation - The company has made adjustments to its fundraising investment plan, which includes changes in project implementation entities and locations, as well as internal investment structure [2][3]. - The total amount of adjusted investment projects is RMB 364,833.04 million, with a remaining balance of RMB 172,124.93 million as of May 31, 2025 [4]. Previous Use of Idle Funds - The company previously used RMB 120,000 million of idle funds to temporarily supplement working capital, which was fully repaid within the stipulated 12-month period [4][5]. Current Use of Idle Funds - The company plans to use up to RMB 150,000 million of idle funds for temporary working capital, with a usage period not exceeding 12 months [6][7]. - The decision to use these funds was approved by the board and the supervisory board, ensuring that it will not impact the funding needs of investment projects [7][8]. Regulatory Compliance - The company has established a special account for the temporary use of idle funds and signed a tripartite supervision agreement with the bank and the sponsor to ensure compliance with regulations [5][6].

Group 1 - The company held its 14th meeting of the second Supervisory Board on June 19, 2025, with all three supervisors present, confirming compliance with relevant laws and regulations [1][2] - The Supervisory Board approved the proposal to temporarily use part of the idle raised funds to supplement working capital, not exceeding RMB 1.5 billion, for a period of up to 12 months [1][2] - The board concluded that this use of funds would not affect the funding needs or project progress of the fundraising projects, adhering to regulatory requirements [1]

Core Viewpoint - Tianyang New Materials (Shanghai) Technology Co., Ltd. has returned part of the temporarily used idle raised funds to improve fund utilization efficiency and save financial costs [1] Group 1: Fund Usage and Return - The company approved the use of up to RMB 40 million of idle raised funds for temporary working capital, related to its main business operations, with a usage period not exceeding 12 months [1] - As of June 4, 2025, the company has returned RMB 35 million to the raised funds account and notified the sponsor institution and representative [1] - By June 18, 2025, the remaining RMB 5 million of the temporarily used funds was also returned to the raised funds account, with notifications sent to the sponsor institution and representative [1] Group 2: Financial Efficiency - The temporary use of idle raised funds has improved the efficiency of fund utilization and saved the company certain financial expenses [1]

一、审议通过了《关于调整闲置募集资金进行现金管理额度和期限的议案》 经审核，我们认为：本次调整闲置募集资金进行现金管理的额度和期限，符 合相关法律法规及公司《募集资金管理办法》的规定，有利于提高募集资金的现 金管理收益，未与募投项目的实施计划相抵触，不会影响募集资金项目建设和公 司正常经营，也不存在变相改变募集资金用途、损害公司及股东利益的情形，相 关审批程序符合法律法规的相关规定。因此，一致同意本次调整闲置募集资金进 行现金管理额度和期限的事项。 二、审议通过了《关于延期归还闲置募集资金并继续用于暂时补充流动资 金的议案》 张家港海锅新能源装备股份有限公司 张家港海锅新能源装备股份有限公司（以下简称"公司"）第四届董事会第 二次独立董事专门会议于 2025 年 6 月 17 日以现场方式召开，会议应出席独立董 事 3 名，实际出席独立董事 3 名，会议由曹承宝先生主持。会议的召开和表决符 合《公司法》《上市公司独立董事管理办法》和《公司章程》等有关规定。与会 独立董事经认真讨论，以举手表决的方式通过如下决议： 表决结果：3 票赞成，0 票反对，0 票弃权。该议案获通过。 表决结果：3 票赞成，0 票反对，0 ...

一、募集资金基本情况 证券代码：603108 证券简称：润达医疗 公告编号：临 2025-029 转债代码：113588 转债简称：润达转债 上海润达医疗科技股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本次使用闲置募集资金暂时补充流动资金的金额不超过 16,000 万元； ●使用期限：自公司董事会审议批准之日起不超过 12 个月。 公司于 2025 年 6 月 13 日召开了第五届董事会第二十三次会议和第五届监事 会第十六次会议审议通过了《关于使用闲置募集资金暂时补充流动资金的议案》， 同意公司使用闲置募集资金不超过 16,000 万元暂时补充流动资金，使用期限自 董事会审议批准之日起不超过 12 个月。现将相关事宜公告如下： 经中国证券监督管理委员会《关于核准上海润达医疗科技股份有限公司公开 发行可转换公司债券的批复》（证监许可【2020】586号）核准，同意上海润达 医疗科技股份有限公司（以下简称"公司"或"润达医疗"）向社会公开发行面 值总额55,000.00万元可转换公司债券，期限6 ...

国金证券股份有限公司 关于上海润达医疗科技股份有限公司 使用闲置募集资金暂时补充流动资金的核查意见 国金证券股份有限公司（以下简称"本保荐机构"）作为上海润达医疗科技股 份有限公司（以下简称"润达医疗"、"公司"）公开发行可转换公司债券的保荐机 构，根据《证券发行上市保荐业务管理办法》、 《上海证券交易所上市公司自律监 管指引第 12 号——可转换公司债券》等相关规定，对润达医疗不提前赎回"润达 转债"事项进行了认真、审慎的核查。核查的具体情况如下： 一、募集资金基本情况 公司《公开发行可转换公司债券募集说明书》披露的募集资金项目以及截至 拟使用募集资金金额 已累计投资金额 序号 项目 | | | 经中国证券监督管理委员会《关于核准上海润达医疗科技股份有限公司公开 发行可转换公司债券的批复》（证监许可【2020】586 号）核准，同意润达医疗 向社会公开发行面值总额 55,000.00 万元可转换公司债券，期限 6 年，共计募集 资金 550,000,000.00 元，扣除承销费用 9,900,000.00 元（不含增值税）后实际收 到的金额为 540,100,000.00 元，上述款项已由主承销商国金证券股 ...

Group 1 - The company has returned all idle raised funds amounting to 180 million yuan to its special account for raised funds, as approved by the board of directors [1][2] - The funds were temporarily used to supplement the company's liquidity for a period not exceeding 12 months [1] - The company has notified the sponsor institution, Guojin Securities Co., Ltd., regarding the return of the funds [1] Group 2 - The company will begin paying interest on its convertible bonds, "Run Da Convertible Bonds," starting from June 17, 2025, for the period from June 17, 2024, to June 16, 2025 [3][4] - The interest payment amount for each bond with a face value of 100 yuan will be 1.80 yuan (including tax) [11][14] - The bond's interest rate for the fifth year is set at 1.8% [11][14] Group 3 - The bond's record date for interest payment is June 16, 2025, and the ex-dividend date is June 17, 2025 [5][15] - The total issuance scale of the convertible bonds is 550 million yuan, with a total of 5.5 million bonds issued [6] - The initial conversion price of the bonds has been adjusted to 13.00 yuan per share as of July 19, 2024, due to profit distribution [10]

Summary of Key Points Core Viewpoint - The company intends to temporarily use idle raised funds to supplement working capital, which is deemed necessary for its operational needs and to enhance the efficiency of fund utilization [1][4][5]. Group 1: Fundraising Overview - The company raised a total of RMB 550,826,094.00 from its initial public offering, with a net amount of RMB 493,480,392.77 after deducting issuance costs [1]. - The company has established strict management protocols for the raised funds, including signing a tripartite supervision agreement with several banks [2]. Group 2: Fund Utilization Status - As of April 30, 2025, the company has committed RMB 33,456.12 million for various projects, with the following investment progress: - Fixture and component expansion project: 50.64% completed - Automation equipment upgrade project: 17.24% completed - R&D center project: 47.39% completed - Information system construction project: 52.25% completed - Working capital supplementation: 104.61% completed due to interest income from idle funds [2][3]. Group 3: Temporary Fund Supplementation Plan - The company plans to use up to RMB 80 million of idle funds for working capital, with a usage period not exceeding 12 months [3][4]. - The rationale for this decision includes recent market acquisitions and the need to address temporary cash flow shortages, which will also help reduce potential interest expenses [4][5]. Group 4: Approval Process - The board of directors and the supervisory board have approved the use of idle funds for working capital, ensuring compliance with relevant regulations and safeguarding the interests of shareholders [5].